Therapeutic drug monitoring versus Bayesian AUC-based dosing for vancomycin in routine practice: a cost–benefit analysis
AUC-based dosing appeared a cost-saving strategy compared with conventional TDM when applying base-case settings of vancomycin-associated AKI risk, treatment and AKI costs.
Authors
- Delphine De Smedt (ORCID: https://orcid.org/0000-0001-7035-8508)
- Pieter De Cock (ORCID: https://orcid.org/0000-0001-7634-7471)
- Barbara Claus
Institutions
- Ghent University Hospital (BE)
- Ghent University (BE)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1093/jac/dkaf011
- Citations
- 3
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 4.19